Alumni

Strengthening Global Capacity Through a New Partnership with the PATH RNA Cooperative and support from the Gates Foundation

admin — Wed, 25 Feb 2026 16:15:11 +0000

Montreal, QC, February 25, 2026 - 91˿��Ƶ’s DNA to RNA (D2R) Initiative - a $165M initiative funded by the Government of Canada through the Canada First Research Excellence Fund to turn genomic discoveries into RNA-based treatments - is expanding its global health impact.

D2R X Norton Rose Fulbright | Protecting Your Ideas: A Guide for Innovators

admin — Tue, 17 Feb 2026 19:40:22 +0000

“Innovation” is everywhere these days—but beyond the buzzword, what does it really mean for a young company, and how can you turn it into a concrete competitive advantage? This presentation demystifies intellectual property (IP) and shows why it matters far more than many founders think.

We’ll explore briefly the different forms of IP and clarify what each protects in practical terms. You’ll discover when an idea becomes an “invention,” when you should consider filing a patent, and who the right professionals are to guide you along the way.

D2R X NRC Biomanufacturing Collaboration Event

admin — Tue, 17 Feb 2026 19:35:18 +0000

A half day showcase of D2R and the National Research Council’s shared biomanufacturing and bioengineering research priorities. Researchers from both the NRC and the D2R community will present on their platform and biomanufacturing-aligned work, including gene editing, mRNA production and optimization, lipid nanoparticle formulation, and RNA therapeutic delivery systems.

D2R X NRC Biomanufacturing Collaboration Event

admin — Tue, 17 Feb 2026 19:35:29 +0000

A half day showcase of D2R and the National Research Council’s shared bio

D2R X Norton Rose Fulbright | Protecting Your Ideas: A Guide for Innovators

admin — Tue, 17 Feb 2026 19:35:05 +0000

“Innovation” is everywhere these days—but beyond the buzzword, what does it really mean for a young company, and how can you turn it into a concrete competitive advantage?

91˿��Ƶ and Moderna Launch Breakthrough RNA Project Through D2R to Advance Made-in-Canada Innovation

admin — Thu, 05 Feb 2026 15:02:33 +0000

Montreal, QC, February 5, 2026 — 91˿��Ƶ researchers, supported by the DNA to RNA (D2R) initiative and Moderna, are launching a pioneering research project that aims to further the fundamentals of ribonucleic acid (RNA) medicines by enhancing our understanding of the three-dimensional structure of full-length messenger RNA (mRNA).

D2R invests over $1.2 million for Postdoctoral Scholars

admin — Wed, 21 Jan 2026 13:02:08 +0000

Montreal, January 21, 2026 – The D2R | DNA to RNA Initiative at 91˿��Ƶ proudly announces the recipients of the inaugural Postdoctoral Scholar Awards. Alongside the Master’s and Doctoral Scholar awards, this funding program recognizes outstanding trainees working on diverse D2R-aligned research projects and brings outstanding postdoctoral researchers from across Canada and abroad to the D2R Initiative.

Interview with Thomas Duchaine: a vaccine that fights COVID-19… and cancer!

admin — Mon, 15 Dec 2025 20:23:03 +0000

D2R's funded-researcher Thomas Duchaine recently sat down with Radio-Canada to discuss emerging research suggesting that RNA vaccines developed for COVID-19 may also enhance the effectiveness of certain cancer treatments.

Call for expressions of interest | Summer 2026 Internship

admin — Fri, 21 Nov 2025 16:07:53 +0000

D2R is excited to announce this brand new opportunity for internships to Black undergraduate students in summer 2026 in partnership with COUHR. COUHR is a student-run non-profit organization partnering with research institutions across Canada to provide funded summer internships for underrepresented undergraduate students in fields such as neuroscience, biophysics, and genetics.

Biochemistry professor Ian Watson awarded Marathon of Hope Cancer Centres Network’s Data Sharing & Use Pilot program funding

admin — Wed, 01 Oct 2025 14:54:27 +0000

D2R awards nearly $1.5 million to Master's and Doctoral Scholars across Canada

admin — Wed, 10 Sep 2025 19:14:17 +0000

Montreal, September 10, 2025 – The DNA to RNA (D2R) initiative at 91˿��Ƶ is proud to announce the recipients of its Master's and Doctoral Scholar Awards, recognizing outstanding and active trainees working on diverse D2R-aligned research projects.

Nineteen new or renewed Canada Research Chairs awarded to 91˿��Ƶ

admin — Wed, 22 Oct 2025 17:06:26 +0000

Federal investment boosts 91˿��Ƶ’s research leadership with over $13 million for Canada Research Chairs

Today, the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, announced over $198 million in federal funding through the Canada Research Chairs (CRC) program, including more than $13 million to support 19 Chairs—nine new and ten renewed—at 91˿��Ƶ.

Event | Breast Cancer & RNA Therapeutics: Exploring inclusive research and career opportunities

admin — Fri, 03 Oct 2025 20:53:13 +0000

Join D2R and the Rosalind and Morris Goodman Cancer Institute (GCI) for an event in honour of Breast Cancer Awareness Month and Women's History Month, in collaboration with Fondation du cancer du sein du Québec and the association Audace au féminin.

91˿��Ƶ researcher awarded Blood Cancer Quality of Life Grant to improve post-transplant care for blood cancer patients and caregivers

admin — Wed, 17 Sep 2025 19:30:22 +0000

Supported by funding from the Leukemia & Lymphoma Society of Canada and the Canadian Cancer Society, Professor Sylvie Lambert and her PhD student, Sarah Chehayeb, will explore how remote monitoring can improve recovery and quality of life for patients undergoing stem cell transplants and ease the burden on their caregivers.

News | David Bujold (C3G) appointed Co-Lead of GA4GH Discovery Work Stream

admin — Thu, 04 Sep 2025 12:46:52 +0000

The Global Alliance for Genomics and Health (GA4GH) has announced new leadership across several initiatives, including the appointment of David Bujold, Data Team Lead at the Canadian Centre for Computational Genomics (C3G)and Bioinformatics Manager at 91˿��Ƶ’s Victor Phillip Dahdaleh Institute of Genomic Medicine, as Co-Lead of the Discovery Work Stream.

Alumni

Strengthening Global Capacity Through a New Partnership with the PATH RNA Cooperative and support from the Gates Foundation

D2R X Norton Rose Fulbright | Protecting Your Ideas: A Guide for Innovators

D2R X NRC Biomanufacturing Collaboration Event

D2R X NRC Biomanufacturing Collaboration Event

D2R X Norton Rose Fulbright | Protecting Your Ideas: A Guide for Innovators

91˿����Ƶ and Moderna Launch Breakthrough RNA Project Through D2R to Advance Made-in-Canada Innovation

D2R invests over $1.2 million for Postdoctoral Scholars

Interview with Thomas Duchaine: a vaccine that fights COVID-19… and cancer!

Call for expressions of interest | Summer 2026 Internship

Biochemistry professor Ian Watson awarded Marathon of Hope Cancer Centres Network’s Data Sharing & Use Pilot program funding

D2R awards nearly $1.5 million to Master's and Doctoral Scholars across Canada

Nineteen new or renewed Canada Research Chairs awarded to 91˿����Ƶ

Event | Breast Cancer & RNA Therapeutics: Exploring inclusive research and career opportunities

91˿����Ƶ researcher awarded Blood Cancer Quality of Life Grant to improve post-transplant care for blood cancer patients and caregivers

News | David Bujold (C3G) appointed Co-Lead of GA4GH Discovery Work Stream

91˿��Ƶ and Moderna Launch Breakthrough RNA Project Through D2R to Advance Made-in-Canada Innovation

Nineteen new or renewed Canada Research Chairs awarded to 91˿��Ƶ

91˿��Ƶ researcher awarded Blood Cancer Quality of Life Grant to improve post-transplant care for blood cancer patients and caregivers